Evaluating Urinary Biomarkers for Early Detection of Kidney Damage in Immune Checkpoint Inhibitors-Treated Patients

Zusammenfassung

Am J Nephrol. 2025 Oct 24. Online ahead of print. doi: 10.1159/000548773 Evaluating Urinary Biomarkers for Early Detection of Kidney Damage in Immune Checkpoint Inhibitors-Treated Patients Alfredo G Casanova Alfredo G Casanova aUnidad de Toxicología. Departamento de Fisiología y Farmacología, Universidad de Salamanca, Salamanca, Spain bInstituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain cTranslational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spa

Kerninformationen

Departamento de Fisiología y Farmacología, Universidad de Salamanca, Salamanca, Spain bInstituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain cTranslational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain Find articles by Marta Prieto a,b,c, Laura Vicen...

This study aimed to validate a panel of urinary biomarkers as diagnostic tools for kidney damage in patients treated with ICIs.Methods A prospective study was conducted on patients scheduled to receive ICIs. Those who subsequently developed kidney damage were considered cases; and those who did not ...

The main organs affected are the skin, liver, lungs, gastrointestinal tract, and endocrine system [3, 4]. Although kidney damage is a relatively uncommon side effect, it deserves attention because it often leads to treatment interruption, which can contribute to a worsening of the patient’s prognosi...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen